Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Publications
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Publications
Find the Latest in:
Find the Latest in:
Opioid Antagonist
Medical Countermeasures
Featured Publication
ACAM2000 Vaccine Safety and Immunogenicity Considerations for Smallpox and Mpox
Read More
July 19, 2026
A Phase 1, Open-Label, Randomized Study to Investigate the Pharmacokinetics and Safety of Multiple Doses of Intranasal Naloxone in Healthy Participants
Read More
April 1, 2026
Improving Inferences Regarding Patient Events Using Emergency Medical Services Response-Based Data
Read More
May 10, 2024
Naloxone Distribution Programs in the Emergency Department: A Scoping Review of the Literature
Read More
View All Opioid Antagonist Publications
August 10, 2026
ACAM2000 Vaccine Safety and Immunogenicity Considerations for Smallpox and Mpox
Read More
March 10, 2026
Lack of Resistance Development During Brincidofovir Therapy in Animal Models of Orthopoxvirus Infection
Read More
January 31, 2026
A Phase 4, Open-Label, Single Arm, Multi-Center Study to Evaluate the Safety of a Smallpox Vaccine in Previously Vaccinated Individuals
Read More
View All Medical Countermeasures Publications
